ArticleInvestigational new drugs2012

Combination of ATP-competitive mammalian target of rapamycin inhibitors with standard chemotherapy for colorectal cancer.

Chloe E Atreya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.